Vimarsana
Biggest News Aggregation in the World

Full Interactive Multimedia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Full Interactive Multimedia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Full Interactive Multimedia Today - Breaking & Trending Today

Astellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause - Vimarsana News

Astellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause

Published: May 12, 2023

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA)...

Source: prnewswire.com
Related Topics:
United StatesAstellas PharmaNaoki OkamuraGenevieve Neal PerryDrug AdministrationJ Public HealthAstellas Pharma IncAstellas IncHead Of Biopharma DevelopmentSchool Of Medicine Department ObstetricsPrnewswire Astellas Pharma IncHealth Qual Life OutcomesFull Interactive MultimediaMedicine DepartmentMarci EnglishVice PresidentBiopharma DevelopmentAstella New Drug ApplicationProvides UpdateFezolinetant New Drug ApplicationPrescribing InformationPatient Product InformationFocus Area ApproachEqual LifePenn Ovarian Aging Study
Astellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause - Vimarsana News

Astellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause

Published: May 12, 2023

 VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause TOKYO, May 12, 2023 /PRNewswire/ -- Astellas Pharma Inc. today... | June 14, 2023

Source: marketscreener.com
Related Topics:
United StatesGenevieve Neal PerryNaoki OkamuraAstellas PharmaPrnewswire Astellas Pharma IncHealth Qual Life OutcomesSchool Of Medicine Department ObstetricsAstellas Pharma IncJ Public HealthDrug AdministrationAstellas IncHead Of Biopharma DevelopmentFull Interactive MultimediaMedicine DepartmentMarci EnglishVice PresidentBiopharma DevelopmentAstella New Drug ApplicationProvides UpdateFezolinetant New Drug ApplicationPrescribing InformationPatient Product InformationFocus Area ApproachEqual LifePenn Ovarian Aging Study